Unichem Laboratories Q4 Results
- BSE: 506690
- NSE: UNICHEMLAB
- ISIN: INE351A01035
- Sector: Major Drugs
BSE
525.25
-20.05 (-3.68%)
-20.05 (-3.68%)Volume6.53 K
Updated: Thu 8 Oct, 2026 | 15:28:45
NSE
529.00-17.20 (-3.15%)
-17.20 (-3.15%)Volume1.64 L
Updated: Thu 8 Oct, 2026 | 15:29:45
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q4 Results Highlights
Quarter ended Mar 26
Note: Comparison is on QoQ basis
Quarterly - Unichem Laboratories Q4 Results
*All figures in crores except per share values
| Fiscal Period | Mar 26 | Dec 25 | QoQ Comp | Mar 24 | YoY Comp |
|---|---|---|---|---|---|
| Total Operating Expense | 570.41 | 507.64 | 12.37% | 662.63 | 6.98% |
| Depreciation/ Amortization | 30.61 | 31.25 | -2.05% | 37.08 | 3.10% |
| Operating Income | 4.71 | 13.53 | -65.19% | -,150.71 | -91.28% |
| Net Income | 10.91 | 264.29 | -95.87% | -,152.59 | -79.40% |
| Other Operating Expenses Total | 166.57 | 140.02 | 18.96% | 151.40 | 16.94% |
| Net Income Before Taxes | 18.79 | 293.43 | -93.60% | -,149.16 | -67.49% |
| Total Revenue | 575.12 | 521.17 | 10.35% | 511.92 | -2.05% |
| Selling/ General/ Admin Expenses Total | 89.81 | 96.23 | -6.67% | 109.56 | -6.90% |
| Diluted Normalized EPS | 2.82 | 2.68 | 5.30% | -10.06 | -62.46% |
EQUITY QUICK LINKS
FROM MARKETS
Trending Stocks
✕
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.